Insider track record
OtherAcross 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Cline Christopher R.. Director active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 15 reports have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €59k. History available since 1 September 2022. The latest transaction was disclosed on 11 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
4,920 sharesCommon StockSEC:0001415889-25-012061:0
48 shares@ US$13.14460.9% of flowCommon StockSEC:0001415889-25-010643:0
21,500 shares0Common StockSEC:0001415889-25-003062:0
865 shares@ US$18.940926.5% of flowCommon StockSEC:0001415889-25-001999:0
6,750 shares0Common StockSEC:0001415889-24-023091:0
514 shares@ US$9.50937.4% of flowCommon StockSEC:0001415889-24-022992:0
54 shares@ US$6.740.6% of flowCommon StockSEC:0001415889-24-010754:0
25,000 shares0Common StockSEC:0001415889-24-002280:0
853 shares@ US$9.068412.0% of flowCommon StockSEC:0001415889-24-001798:0
457 shares@ US$14.710210.6% of flowCommon StockSEC:0001209191-23-048258:0
455 shares@ US$16.5911.6% of flowCommon StockSEC:0001209191-23-029023:0
47 shares@ US$21.491.6% of flowCommon StockSEC:0001209191-23-024205:0
20,250 shares0Common StockSEC:0001209191-23-006422:0
852 shares@ US$21.904428.9% of flowCommon StockSEC:0001209191-23-005032:0
5,000 shares0Common StockSEC:0001209191-22-048347:0